J&J reports 18,000 new prescriptions for Icotyde in first full quarter
read at Endpoints ↗Positive readoutPositive
Johnson & Johnson gave an update on the launch of its plaque-psoriasis drug Icotyde.
The company said that in its first full quarter on the market, Icotyde generated about 18,000 new prescriptions, showing early uptake.
J&J did not disclose revenue figures for the period, leaving the financial impact unclear.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “J&J touts Icotyde prescriptions, but not sales, in first full quarter”
read at Endpoints ↗82 words · retrieved Jul 15
comments(0)
5-min edit window · permanent after that